Join the Pancreatic Cancer group to help and get support from people like you.
Pancreatic Cancer News
Related terms: Cancer, Pancreas, Cancer, Pancreatic, Pancreatic Carcinoma
2000 to 2021 Saw Increase in Incidence of Pancreatic Adenocarcinoma
WEDNESDAY, April 23, 2025 – From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study published online April 14...
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
THURSDAY, April 17, 2025 – Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are less likely to achieve...
Nanosensor Assay Promising for Pancreatic Cancer Detection
FRIDAY, Feb. 28, 2025 – A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal adenocarcinoma (PDAC) samples with high specificity...
Vaccine Shows Promise for Pancreatic Cancer, Study Finds
FRIDAY, Feb. 21, 2025 – Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer...
Could MRI Spot 'Pre-Cancer' Lesions of the Pancreas?
TUESDAY, Dec. 17, 2024 (HeathDay News) – Pancreatic cancer can be a silent killer – the organ is located deep inside the body, making cancer harder to detect before it becomes life-threatening. ...
FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) – Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage oncology company developing innovative,...
Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients
FRIDAY, Nov. 22, 2024 – Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with advanced pancreatic ductal adenocarcinoma (PDA), according...
Why Alarm Is Easing Over a Rise in Pancreatic Cancer Among the Young
TUESDAY, Nov. 19, 2024 – Experts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in...
Study Looks at Increasing Incidence of Pancreatic Cancer in Younger Adults
TUESDAY, Nov. 19, 2024 – The increasing incidence of pancreatic cancer in young Americans is mainly due to increased detection of smaller, early-stage endocrine cancer, according to a research...
Anxiety, Depression Increased in Pancreatic Cancer Patients With Palliative Care Consult
FRIDAY, Nov. 15, 2024 – Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of anxiety and depression, according to a study recently...
American College of Gastroenterology, Oct. 25-30
The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted participants from around the world, including gastroenterology and digestive d...
Most Adults Lack Knowledge About Pancreatic Cancer
TUESDAY, Nov. 5, 2024 – Most people continue to believe that pancreatic cancer affects only the elderly and that there is nothing they can do to reduce their risk, according to the results of a new...
What You Don't Know About Pancreatic Cancer Could Harm You
WEDNESDAY, Oct. 30, 2024 – Pancreatic cancer rates are rising in adults younger than 50, but many continue to believe it’s a disease that only affects the elderly, a new survey shows. Folks in that a...
Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity
WEDNESDAY, Oct. 9, 2024 – For individuals with obesity, metabolic-bariatric surgery (MBS) is associated with a reduced risk for pancreatic cancer, especially among those with type 2 diabetes (T2D),...
Most Patients With Stage I PDAC Are Upstaged on Histopathology
MONDAY, Sept. 9, 2024 – More than 70 percent of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and close to 30 percent with stage II PDAC are upstaged on histopathology, according to...